Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 30

1.

Prevalence and risk factors for HIV-1 infection in people who use illicit drugs in northern Brazil.

Oliveira-Filho AB, Silva FQ, Santos FJA, Cardoso YMN, Di Miceli JFF, Resque RL, Silva-Oliveira GC, Martins LC, Pinheiro LML, Machado LFA, Pinto AR, Lemos JAR, Fischer B, Kupek E.

Trans R Soc Trop Med Hyg. 2019 Nov 20. pii: trz106. doi: 10.1093/trstmh/trz106. [Epub ahead of print]

PMID:
31746322
2.

Diabetic macular edema treated with intravitreal aflibercept injection after treatment with other anti-VEGF agents (SWAP-TWO study): 6-month interim analysis.

Babiuch AS, Conti TF, Conti FF, Silva FQ, Rachitskaya A, Yuan A, Singh RP.

Int J Retina Vitreous. 2019 Jul 23;5:17. doi: 10.1186/s40942-019-0167-x. eCollection 2019.

3.

Hepatitis C virus infection status and associated factors among a multi-site sample of people who used illicit drugs in the Amazon region.

Oliveira-Filho AB, Santos FJA, Silva FQ, Raiol NC, Costa CCS, Piauiense JNF, Martins LC, Cardoso YMN, Di Miceli JFF, Resque RL, Silva-Oliveira GC, Pinheiro LML, Machado LFA, Pinho JRR, Lemos JAR, Kupek E, Fischer B.

BMC Infect Dis. 2019 Jul 17;19(1):634. doi: 10.1186/s12879-019-4270-2.

4.

Long-Term Assessment of Macular Atrophy in Patients with Age-Related Macular Degeneration Receiving Anti-Vascular Endothelial Growth Factor.

Li A, Rieveschl NB, Conti FF, Silva FQ, Sears JE, Srivastava S, Ehlers JP, Schachat AP, Babiuch AS, Kaiser PK, Martin DF, Singh RP.

Ophthalmol Retina. 2018 Jun;2(6):550-557. doi: 10.1016/j.oret.2017.10.010. Epub 2017 Dec 19.

PMID:
31047607
5.

Difference in Treatment Effect Between Intravitreal Aflibercept Injection and Laser by Baseline Factors in Diabetic Macular Edema.

Singh RP, Silva FQ, Gibson A, Thompson D, Vitti R, Berliner AJ, Saroj N.

Ophthalmic Surg Lasers Imaging Retina. 2019 Mar 1;50(3):167-173. doi: 10.3928/23258160-20190301-06.

PMID:
30893450
6.

Characterization of Patients With Geographic Atrophy in Routine Clinical Practice.

Conti F, Han MM, Song W, Wai KM, Silva FQ, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2019 Feb 1;50(2):93-98. doi: 10.3928/23258160-20190129-05.

PMID:
30768216
7.

Baseline Ocular Characteristics of Patients Undergoing Initiation of Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema.

Ansari WH, Han MM, Haq S, Conti FF, Silva FQ, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2019 Feb 1;50(2):69-75. doi: 10.3928/23258160-20190129-02.

PMID:
30768213
8.

Characterization of the Systemic Findings of Patients Undergoing Initiation of Anti-Vascular Endothelial Growth Factor Therapy for Diabetic Macular Edema in Routine Clinical Practice.

Haq S, Ansari WH, Han MM, Conti TF, Conti FF, Silva FQ, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2019 Jan 1;50(1):16-24. doi: 10.3928/23258160-20181212-03.

PMID:
30640391
9.

Outer Retinal Tubulation and Neovascular Age-Related Macular Degeneration: A Review of the Pathogenesis and Clinical Implications.

Damasceno NA, Damasceno EF, Silva FQ, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2018 Nov 1;49(11):870-876. doi: 10.3928/23258160-20181101-08. Review.

PMID:
30457646
10.

Association of Disorganization of Retinal Inner Layers With Visual Acuity Response to Anti-Vascular Endothelial Growth Factor Therapy for Macular Edema Secondary to Retinal Vein Occlusion.

Babiuch AS, Han M, Conti FF, Wai K, Silva FQ, Singh RP.

JAMA Ophthalmol. 2019 Jan 1;137(1):38-46. doi: 10.1001/jamaophthalmol.2018.4484.

11.

Repeatability of Split-Spectrum Amplitude-Decorrelation Angiography to Assess Capillary Perfusion Density Within Optical Coherence Tomography.

Conti FF, Young JM, Silva FQ, Rodrigues EB, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2018 Sep 1;49(9):e9-e19. doi: 10.3928/23258160-20180907-02.

PMID:
30222814
12.

36-Month Evaluation of Intravitreous Aflibercept Injection for Wet Age-Related Macular Degeneration in Patients Previously Treated With Ranibizumab or Bevacizumab.

Conti FF, Silva FQ, Srivastava SK, Ehlers JP, Schachat AP, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2018 Mar 1;49(3):179-185. doi: 10.3928/23258160-20180221-05.

PMID:
29554385
13.

Switching Anti-Vascular Endothelial Growth Factors in Refractory Neovascular Age-Related Macular Degeneration.

Ashraf M, Banaee T, Silva FQ, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2018 Mar 1;49(3):166-170. doi: 10.3928/23258160-20180221-03. Review.

PMID:
29554383
14.

Long-term Clinical Outcomes of Pars Plana Versus Anterior Chamber Placement of Glaucoma Implant Tubes.

Qin VL, Kaleem M, Conti FF, Rockwood EJ, Singh A, Sood-Mendiratta S, Sears JE, Silva FQ, Eisengart J, Singh RP.

J Glaucoma. 2018 May;27(5):440-444. doi: 10.1097/IJG.0000000000000931.

PMID:
29521717
15.

The Prevalence of Adverse Ocular Hemorrhagic Events in Patients Utilizing Oral Anticoagulant and Antiplatelet Therapy in Routine Clinical Practice.

Sudarshana DM, Konstantinou EK, Arepalli S, Silva FQ, Schachat AP, Ehlers JP, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2018 Jan 1;49(1):27-34. doi: 10.3928/23258160-20171215-04.

PMID:
29304263
16.

Non-Mydriatic Ultra-Widefield Imaging Compared With Single-Field Imaging in the Evaluation of Peripheral Retinal Pathology.

Adhi M, Silva FQ, Lang R, Seballos R, Sukol RB, Feinleib S, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2017 Dec 1;48(12):962-968. doi: 10.3928/23258160-20171130-02.

PMID:
29253298
17.

Hepatitis C virus infection among illicit drug users in an archipelago of the Amazon.

Silva FQ, Santos FJA, Andrade AP, Pacheco SDB, Fischer B, Pinho JRR, Lemos JAR, Oliveira-Filho AB.

Arch Virol. 2018 Mar;163(3):617-622. doi: 10.1007/s00705-017-3656-y. Epub 2017 Nov 21.

PMID:
29164400
18.

OUTCOMES OF PATIENTS WITH EXUDATIVE AGE-RELATED MACULAR DEGENERATION TREATED WITH ANTIVASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR THREE OR MORE YEARS: A Review of Current Outcomes.

Qin VL, Young J, Silva FQ, Conti FF, Singh RP.

Retina. 2018 Aug;38(8):1500-1508. doi: 10.1097/IAE.0000000000001753. Review.

PMID:
28671895
19.

Comparison of Ranibizumab and Bevacizumab for Macular Edema Secondary to Retinal Vein Occlusions in Routine Clinical Practice.

Khan M, Wai KM, Silva FQ, Srivastava S, Ehlers JP, Rachitskaya A, Babiuch A, Deasy R, Kaiser PK, Schachat AP, Yuan A, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2017 Jun 1;48(6):465-472. doi: 10.3928/23258160-20170601-04.

PMID:
28613352
20.

A retrospective study of the influence of the vitreomacular interface on macular oedema secondary to retinal vein occlusion.

Singh RP, Habbu KA, Bedi R, Silva FQ, Ehlers JP, Schachat AP, Sears JE, Srivastava SK, Kaiser PK, Yuan A.

Br J Ophthalmol. 2017 Oct;101(10):1340-1345. doi: 10.1136/bjophthalmol-2016-309747. Epub 2017 Mar 3.

PMID:
28258075
21.

Outcomes of Diabetic Macular Edema Patients by Baseline Hemoglobin A1c: Analyses from VISTA and VIVID.

Singh RP, Wykoff CC, Brown DM, Larsen M, Terasaki H, Silva FQ, Saroj N, Gibson A, Vitti R, Kayshap S, Berliner AJ, Zeitz O, Metzig C, Thompson D, Nguyen QD.

Ophthalmol Retina. 2017 Sep - Oct;1(5):382-388. doi: 10.1016/j.oret.2017.02.003. Epub 2017 Apr 17.

PMID:
31047565
22.

A 24-Month Evaluation of Aflibercept for Wet Age-Related Macular Degeneration in Patients Previously Receiving Ranibizumab or Bevacizumab.

Silva FQ, Srivastava S, Ehlers JP, Li A, Bedi R, Schachat AP, Singh RP.

Ophthalmol Retina. 2017 Mar - Apr;1(2):111-117. doi: 10.1016/j.oret.2016.09.008. Epub 2016 Nov 23.

PMID:
31047267
23.

Evaluation and Referral of Diabetic Eye Disease in the Endocrinology and Primary Care Office Settings.

Silva FQ, Adhi M, Wai KM, Olansky L, Lansang MC, Singh RP.

Ophthalmic Surg Lasers Imaging Retina. 2016 Oct 1;47(10):930-934. doi: 10.3928/23258160-20161004-06.

PMID:
27759859
24.

Characterization of hepatitis B virus infection in illicit drug users in the Marajó Archipelago, northern Brazil.

Andrade AP, Pacheco SDB, Silva FQ, Pinheiro LML, Castro JAA, Amaral CEM, Hermes RB, Fischer B, Pinho JRR, Lemos JAR, Oliveira-Filho AB.

Arch Virol. 2017 Jan;162(1):227-233. doi: 10.1007/s00705-016-3060-z. Epub 2016 Oct 7.

PMID:
27718074
25.

Impact of initial visual acuity on anti-VEGF treatment outcomes in patients with macular oedema secondary to retinal vein occlusions in routine clinical practice.

Wai KM, Khan M, Srivastava S, Rachitskaya A, Silva FQ, Deasy R, Schachat AP, Babiuch A, Ehlers JP, Kaiser PK, Yuan A, Singh RP.

Br J Ophthalmol. 2017 May;101(5):574-579. doi: 10.1136/bjophthalmol-2016-308727. Epub 2016 Aug 8.

PMID:
27503394
27.

Association of blood and ocular perfusion pressure with structural glaucomatous progression by flicker chronoscopy.

McGlynn MM, Ehrlich JR, Marlow ED, Chee RI, Silva FQ, Van Tassel SH, Radcliffe NM.

Br J Ophthalmol. 2013 Dec;97(12):1569-73. doi: 10.1136/bjophthalmol-2013-303655. Epub 2013 Sep 24.

PMID:
24064938
28.

Relationship between corneal hysteresis and optic nerve parameters measured with spectral domain optical coherence tomography.

Vu DM, Silva FQ, Haseltine SJ, Ehrlich JR, Radcliffe NM.

Graefes Arch Clin Exp Ophthalmol. 2013 Jul;251(7):1777-83. doi: 10.1007/s00417-013-2311-x. Epub 2013 Mar 22.

PMID:
23519885
29.

Agreement of flicker chronoscopy for structural glaucomatous progression detection and factors associated with progression.

Chee RI, Silva FQ, Ehrlich JR, Radcliffe NM.

Am J Ophthalmol. 2013 Jun;155(6):983-990.e1. doi: 10.1016/j.ajo.2013.01.005. Epub 2013 Feb 22.

PMID:
23462231
30.

[Syndrome of aplasia of muscles of the anterior abdominal wall (author's transl)].

Arap S, Denes F, Silva FQ, de Goes GM.

J Urol Nephrol (Paris). 1978 Mar;84(3):161-71. French. No abstract available.

PMID:
25345

Supplemental Content

Loading ...
Support Center